Skip to main content

Advertisement

Log in

Psychological impact of serial prostate-specific antigen tests in Japanese men waiting for prostate biopsy

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

It is common to repeat prostate-specific antigen (PSA) measurements for men with intermediate PSA elevation before prostate biopsy. In this scenario, men with persistently elevated PSA values may have considerable psychological distress. We attempted to determine whether elevated PSA values have psychological effects on these men in association with the timing of measurement, PSA kinetics, and biopsy results.

Methods

In order to investigate the initial and late effects of PSA tests on psychological distress during serial measurements, two groups of men with screen-positive results (PSA ≥3 ng/ml) were studied—205 men whose first questionnaires regarding anxiety and depression were taken at initial screening (group A), and 103 men whose questionnaires were taken at repeated measurement for prior PSA elevation (group B).

Results

The level of distress was generally low. There were no significant differences in distress between the two groups, suggesting a constant psychological effect by elevated PSA values over a long period of time. The distress of men in group A increased significantly as PSA levels rose and decreased when they fell to normal range. On the other hand, the distress of men in group B did not change regardless of PSA kinetics, indicating that their psychological condition seemed susceptible to subtle PSA change only in the initial phase of measurements. Unexpectedly, men with benign results showed insignificant but higher distress after prostate biopsy.

Conclusions

Although a small fraction of men have psychological distress caused by changes in PSA levels, the benefits, risks (psychological and physical), and limitations of PSA tests must be adequately explained to the patients before entering the screening program.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Schröder FH, Hugosson J, Roobol MJ, ERSPC Investigators et al (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360:1320–1328

    Article  PubMed  Google Scholar 

  2. Andriole GL, Crawford ED, Grubb RL, PLCO Project Team et al (2009) Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360:1310–1319

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Carlsson S, Vickers AJ, Roobol M et al (2012) Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review. J Clin Oncol 30:2581–2584

    Article  PubMed  PubMed Central  Google Scholar 

  4. Heidenreich A, Bastian PJ, Bellmunt J et al (2014) European Association of Urology. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update. Eur Urol 65:124–137

    Article  PubMed  Google Scholar 

  5. Nukaga K, Matsuda T, Sobue T (2012) Prediction of the future incidence of cancer in Japan. In: Sobue T, Katanoda K, Ajiki W, Tsukuma H, Ioka A (eds) White paper on cancer and statistics 2012 (in Japanese). Shinohara Shuppan Shin-ha, Tokyo, pp 63–81

    Google Scholar 

  6. Cancer Registration Committee of the Japanese Urological Association (2005) Clinicopathological statistics on registered prostate cancer patients in Japan: 2000 report from the Japanese Urological Association. Int J Urol 12:46–61

    Article  Google Scholar 

  7. Zisman A, Leibovici D, Kleinmann J et al (2001) The impact of prostate biopsy on patient well-being: a prospective study of pain, anxiety and erectile dysfunction. J Urol 165:445–454

    Article  CAS  PubMed  Google Scholar 

  8. Fowler FJ Jr, Barry MJ, Walker-Corkery B et al (2006) The impact of a suspicious prostate biopsy on patients’ psychological, socio-behavioral, and medical care outcomes. J Gen Intern Med 21:715–721

    Article  PubMed  PubMed Central  Google Scholar 

  9. Katz DA, Jarrard DF, McHorney CA et al (2007) Health perceptions in patients who undergo screening and workup for prostate cancer. Urology 69:215–220

    Article  PubMed  PubMed Central  Google Scholar 

  10. Wade J, Rosario DJ, Macefield RC et al (2013) Psychological impact of prostate biopsy: physical symptoms, anxiety, and depression. J Clin Oncol 31:4235–4241

    Article  PubMed  Google Scholar 

  11. Oba A, Nakaya N, Hasumi M et al (2014) Psychosocial longitudinal study profile and distress of couples in relation to the conduct of prostate biopsy. Jpn J Clin Oncol 44:463–471

    Article  PubMed  Google Scholar 

  12. Dowrick AS, Wootten AC, Howard N et al (2016) A prospective study of the short-term quality of life outcomes of patients undergoing transperineal prostate biopsy. BJU Int. doi:10.1111/bju.13413 (in press)

    PubMed  Google Scholar 

  13. Benson MC, Whang IS, Pantuck A et al (1992) Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 147:815–816

    CAS  PubMed  Google Scholar 

  14. Neal DE Jr, Clejan S, Sarma D et al (1992) Prostate specific antigen and prostatitis. I. Effect of prostatitis on serum PSA in the human and nonhuman primate. Prostate 20:105–111

    Article  PubMed  Google Scholar 

  15. Bunting PS, DeBoer G, Choo R et al (2002) Intraindividual variation of PSA, free PSA and complexed PSA in a cohort of patients with prostate cancer managed with watchful observation. Clin Biochem 305:471–475

    Article  Google Scholar 

  16. Kobayashi M, Kurokawa S, Tokue A (2005) Intraindividual variation in total and percent free prostate-specific antigen levels in prostate cancer suspects. Urol Int 74:198–202

    Article  CAS  PubMed  Google Scholar 

  17. Bruun L, Becker C, Hugosson J et al (2005) Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in Sweden. Prostate 650:216–221

    Article  Google Scholar 

  18. Essink-Bot ML, de Koning HJ, Nijs HG et al (1998) Short-term effects of population-based screening for prostate cancer on health-related quality of life. J Natl Cancer Inst 90:925–931

    Article  CAS  PubMed  Google Scholar 

  19. Brindle LA, Oliver SE, Dedman D et al (2006) Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK. BJU Int 98:777–782

    Article  PubMed  Google Scholar 

  20. Carlsson S, Aus G, Wessman C et al (2007) Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA)—Results from a prospective, population-based, randomised study. Eur J Cancer 43:2109–2116

    Article  PubMed  Google Scholar 

  21. Awsare NS, Green JS, Aldwinckle B et al (2008) The measurement of psychological distress in men being investigated for the presence of prostate cancer. Prostate Cancer Prostatic Dis 11:384–389

    Article  CAS  PubMed  Google Scholar 

  22. Macefield RC, Metcalfe C, Lane JA, ProtecT Study Group et al (2010) Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result. Br J Cancer 102:1335–1340

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370

    Article  CAS  PubMed  Google Scholar 

  24. Bjelland I, Dahl AA, Haug TT et al (2002) The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 52:69–77

    Article  PubMed  Google Scholar 

  25. Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 48:452–458

    Article  CAS  PubMed  Google Scholar 

  26. Schröder FH, Hugosson J, Roobol MJ et al (2012) Prostate-cancer mortality at 11 years of follow-up. N Engl J Med 366:981–990

    Article  PubMed  Google Scholar 

  27. Hugosson J, Carlsson S, Aus G et al (2010) Mortality results from the Göteborg randomised population-based prostate-cancer screening trial. Lancet Oncol 11:725–732

    Article  PubMed  PubMed Central  Google Scholar 

  28. Committee for Establishment of the Guidelines on Screening for Prostate Cancer; Japanese Urological Association (2010) Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010. Int J Urol 17:830–883

    Article  Google Scholar 

  29. Rosario DJ, Lane JA, Metcalfe C, ProtecT Study Group et al (2008) Contribution of a single repeat PSA test to prostate cancer risk assessment: experience from the ProtecT study. Eur Urol 53:777–784

    Article  PubMed  Google Scholar 

  30. McGovern PM, Gross CR, Krueger RA et al (2004) False-positive cancer screens and health-related quality of life. Cancer Nurs 27:347–352

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Minoru Kobayashi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kobayashi, M., Nukui, A. & Kamai, T. Psychological impact of serial prostate-specific antigen tests in Japanese men waiting for prostate biopsy . Int J Clin Oncol 22, 174–180 (2017). https://doi.org/10.1007/s10147-016-1038-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-016-1038-1

Keywords

Navigation